Prognostic and predictive impact of neutrophil‐to‐lymphocyte ratio and HLA‐I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become standard‐of‐care in patients with pretreated advanced esophageal squamous cell carcinoma (ESCC). However, reliable biomarkers for clinical outcomes are lacking for ICIs. The exploration of effective biomarkers is therefore needed to optimiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Zhu, Yanrong, Zhang, Bo, Wang, Xi, Mo, Hongnan, Jiao, Yuchen, Xu, Jiachen, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161342/
https://www.ncbi.nlm.nih.gov/pubmed/35437954
http://dx.doi.org/10.1111/1759-7714.14431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161342/
https://www.ncbi.nlm.nih.gov/pubmed/35437954
http://dx.doi.org/10.1111/1759-7714.14431

Ejemplares similares